Agents Increasing Serum Potassium + Olmesartan Medoxomil And Hydrochlorothiazide Interaction
Moderateinteraction on record
Description
Coadministration may result in hyperkalemia. Monitor serum potassium in patients receiving concomitant potassium-raising agents.
Mechanism
Olmesartan medoxomil increases serum potassium; additive effect with other potassium-raising drugs
Source: NLP:olmesartan medoxomil and hydrochlorothiazide